Cellectar Biosciences, Inc. Share Price

Cellectar Biosciences, Inc. Share Price

NASDAQ: CLRB | Micro Cap
$1.25
+0.00 (0.00%) Last updated on 29 Oct, 2026 | 19:50 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cellectar Biosciences, Inc. Stock Performance

Open
$1.25
Prev. Close
$1.25
Circuit Range
N/A
Day Range
$1.25 - $1.25
Year Range
$1.12 - $4.68
Volume
201
Average Traded
$1.25

Cellectar Biosciences, Inc. Share Price Today

As of 29 October 2026, Cellectar Biosciences, Inc.'s share price is $1.25. The stock opened at $1.25, compared to its previous close of $1.25. During today's trading session, Cellectar Biosciences, Inc.'s share price traded between $1.25 and $1.25, with an average price of $1.25. Over the past 52 weeks, the stock has recorded a high of $4.68 and a low of $1.12. In terms of performance, Cellectar Biosciences, Inc.'s share price has declined by 52.47% over the last six months and is down 63.13% on a year-on-year basis.

Cellectar Biosciences, Inc. Share Price Chart

Line chart of the Cellectar Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 1.24 to 1.25, ending at 1.25.
$1.25$1.25
L
Show Current Price
H

Cellectar Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-74.73%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-56.08%

Cellectar Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.44-$5.30-$5.65-$6.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-19.37%-6.60%-22.65%

Cellectar Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$31.79-$42.77-$44.58-$21.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.54%-4.23%51.12%

About Cellectar Biosciences, Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Cellectar Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.86
$1.25
-32.07%
Sep 2026
$2.45
$1.84
-26.98%
Aug 2026
$2.60
$2.52
-3.82%
Jul 2026
$2.83
$2.62
-6.43%
Jun 2026
$3.12
$2.80
-13.04%
May 2026
$2.64
$3.22
+22.43%
Apr 2026
$2.87
$2.63
+6.48%
Mar 2026
$3.02
$2.47
-26.27%
Feb 2026
$3.11
$3.35
+5.68%
Jan 2026
$3.56
$3.17
+9.31%
Dec 2025
$3.58
$2.90
-19.67%
Nov 2025
$3.26
$3.61
+6.49%

CLRB Share Price FAQs